Request for Covid-19 Impact Assessment of this Report
The United States Plasma Protein Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Plasma Protein Therapeutics market, reaching US$ million by the year 2028. As for the Europe Plasma Protein Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Plasma Protein Therapeutics players cover Shire (Baxalta), CSL, Grifols, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Protein Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Coagulation Factor
Immune Globulin
Albumin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hemophilia
PID
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma Protein Therapeutics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2017, 2022 & 2028
2.2 Plasma Protein Therapeutics Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Others
2.3 Plasma Protein Therapeutics Sales by Type
2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)
2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2017-2022)
2.4 Plasma Protein Therapeutics Segment by Application
2.4.1 Hemophilia
2.4.2 PID
2.4.3 Others
2.5 Plasma Protein Therapeutics Sales by Application
2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2017-2022)
2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2017-2022)
3 Global Plasma Protein Therapeutics by Company
3.1 Global Plasma Protein Therapeutics Breakdown Data by Company
3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2020-2022)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2022)
3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2020-2022)
3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2020-2022)
3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2022)
3.3 Global Plasma Protein Therapeutics Sale Price by Company
3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution
3.4.2 Players Plasma Protein Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Plasma Protein Therapeutics by Geographic Region
4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2017-2022)
4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region
4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2017-2022)
4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region
4.3 Americas Plasma Protein Therapeutics Sales Growth
4.4 APAC Plasma Protein Therapeutics Sales Growth
4.5 Europe Plasma Protein Therapeutics Sales Growth
4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth
5 Americas
5.1 Americas Plasma Protein Therapeutics Sales by Country
5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2017-2022)
5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2017-2022)
5.2 Americas Plasma Protein Therapeutics Sales by Type
5.3 Americas Plasma Protein Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Protein Therapeutics Sales by Region
6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2017-2022)
6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2017-2022)
6.2 APAC Plasma Protein Therapeutics Sales by Type
6.3 APAC Plasma Protein Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Plasma Protein Therapeutics by Country
7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2017-2022)
7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2017-2022)
7.2 Europe Plasma Protein Therapeutics Sales by Type
7.3 Europe Plasma Protein Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasma Protein Therapeutics by Country
8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2017-2022)
8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type
8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics
10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
10.4 Industry Chain Structure of Plasma Protein Therapeutics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Protein Therapeutics Distributors
11.3 Plasma Protein Therapeutics Customer
12 World Forecast Review for Plasma Protein Therapeutics by Geographic Region
12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region
12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2023-2028)
12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma Protein Therapeutics Forecast by Type
12.7 Global Plasma Protein Therapeutics Forecast by Application
13 Key Players Analysis
13.1 Shire (Baxalta)
13.1.1 Shire (Baxalta) Company Information
13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Offered
13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shire (Baxalta) Main Business Overview
13.1.5 Shire (Baxalta) Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Protein Therapeutics Product Offered
13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Protein Therapeutics Product Offered
13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Protein Therapeutics Product Offered
13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Protein Therapeutics Product Offered
13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Protein Therapeutics Product Offered
13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Protein Therapeutics Product Offered
13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Protein Therapeutics Product Offered
13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma Protein Therapeutics Product Offered
13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Plasma Protein Therapeutics Product Offered
13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Plasma Protein Therapeutics Product Offered
13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Kamada
13.12.1 Kamada Company Information
13.12.2 Kamada Plasma Protein Therapeutics Product Offered
13.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Kamada Main Business Overview
13.12.5 Kamada Latest Developments
14 Research Findings and Conclusion
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2017-2022) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2022)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2017-2022)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2022)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2020-2022) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2022)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2022)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2017-2022)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2017-2022)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)
Table 39. Americas Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 40. Americas Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)
Table 41. Americas Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 42. Americas Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)
Table 43. APAC Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)
Table 44. APAC Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)
Table 45. APAC Plasma Protein Therapeutics Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2017-2022)
Table 47. APAC Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 48. APAC Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)
Table 49. APAC Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 50. APAC Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)
Table 51. Europe Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 52. Europe Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)
Table 53. Europe Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)
Table 55. Europe Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 56. Europe Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)
Table 57. Europe Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 58. Europe Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 68. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 69. Key Industry Trends of Plasma Protein Therapeutics
Table 70. Plasma Protein Therapeutics Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Plasma Protein Therapeutics Distributors List
Table 73. Plasma Protein Therapeutics Customer List
Table 74. Global Plasma Protein Therapeutics Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Plasma Protein Therapeutics Sales Market Forecast by Region
Table 76. Global Plasma Protein Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Plasma Protein Therapeutics Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Plasma Protein Therapeutics Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Plasma Protein Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Plasma Protein Therapeutics Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Plasma Protein Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2023-2028)
Table 94. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Shire (Baxalta) Plasma Protein Therapeutics Product Offered
Table 96. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Shire (Baxalta) Main Business
Table 98. Shire (Baxalta) Latest Developments
Table 99. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Plasma Protein Therapeutics Product Offered
Table 101. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. CSL Main Business
Table 103. CSL Latest Developments
Table 104. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Grifols Plasma Protein Therapeutics Product Offered
Table 106. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Grifols Main Business
Table 108. Grifols Latest Developments
Table 109. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. Octapharma Plasma Protein Therapeutics Product Offered
Table 111. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Octapharma Main Business
Table 113. Octapharma Latest Developments
Table 114. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. Kedrion Plasma Protein Therapeutics Product Offered
Table 116. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Kedrion Main Business
Table 118. Kedrion Latest Developments
Table 119. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. LFB Group Plasma Protein Therapeutics Product Offered
Table 121. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. LFB Group Main Business
Table 123. LFB Group Latest Developments
Table 124. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 125. Biotest Plasma Protein Therapeutics Product Offered
Table 126. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Biotest Main Business
Table 128. Biotest Latest Developments
Table 129. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 130. BPL Plasma Protein Therapeutics Product Offered
Table 131. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. BPL Main Business
Table 133. BPL Latest Developments
Table 134. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 135. RAAS Plasma Protein Therapeutics Product Offered
Table 136. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. RAAS Main Business
Table 138. RAAS Latest Developments
Table 139. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 140. CBPO Plasma Protein Therapeutics Product Offered
Table 141. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. CBPO Main Business
Table 143. CBPO Latest Developments
Table 144. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 145. Hualan Bio Plasma Protein Therapeutics Product Offered
Table 146. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. Hualan Bio Main Business
Table 148. Hualan Bio Latest Developments
Table 149. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 150. Kamada Plasma Protein Therapeutics Product Offered
Table 151. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 152. Kamada Main Business
Table 153. Kamada Latest Developments
List of Figures
Figure 1. Picture of Plasma Protein Therapeutics
Figure 2. Plasma Protein Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Plasma Protein Therapeutics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Coagulation Factor
Figure 10. Product Picture of Immune Globulin
Figure 11. Product Picture of Albumin
Figure 12. Product Picture of Others
Figure 13. Global Plasma Protein Therapeutics Sales Market Share by Type in 2021
Figure 14. Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2022)
Figure 15. Plasma Protein Therapeutics Consumed in Hemophilia
Figure 16. Global Plasma Protein Therapeutics Market: Hemophilia (2017-2022) & (K Units)
Figure 17. Plasma Protein Therapeutics Consumed in PID
Figure 18. Global Plasma Protein Therapeutics Market: PID (2017-2022) & (K Units)
Figure 19. Plasma Protein Therapeutics Consumed in Others
Figure 20. Global Plasma Protein Therapeutics Market: Others (2017-2022) & (K Units)
Figure 21. Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)
Figure 22. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2021
Figure 23. Plasma Protein Therapeutics Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2021
Figure 25. Global Plasma Protein Therapeutics Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2021
Figure 27. Global Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)
Figure 28. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region in 2021
Figure 29. Americas Plasma Protein Therapeutics Sales 2017-2022 (K Units)
Figure 30. Americas Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)
Figure 31. APAC Plasma Protein Therapeutics Sales 2017-2022 (K Units)
Figure 32. APAC Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)
Figure 33. Europe Plasma Protein Therapeutics Sales 2017-2022 (K Units)
Figure 34. Europe Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Plasma Protein Therapeutics Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)
Figure 37. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2021
Figure 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country in 2021
Figure 39. United States Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2021
Figure 44. APAC Plasma Protein Therapeutics Revenue Market Share by Regions in 2021
Figure 45. China Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2021
Figure 52. Europe Plasma Protein Therapeutics Revenue Market Share by Country in 2021
Figure 53. Germany Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country in 2021
Figure 60. Egypt Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2021
Figure 66. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 67. Industry Chain Structure of Plasma Protein Therapeutics
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...